465 related articles for article (PubMed ID: 29330357)
41. MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer.
Liu J; Quan Z; Gao Y; Wu X; Zheng Y
Biochem Biophys Res Commun; 2021 Oct; 576():73-79. PubMed ID: 34482026
[TBL] [Abstract][Full Text] [Related]
42. Knockdown of PLCε inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells.
Yang X; Ou L; Tang M; Wang Y; Wang X; Chen E; Diao J; Wu X; Luo C
Tumour Biol; 2015 Dec; 36(12):9723-32. PubMed ID: 26156799
[TBL] [Abstract][Full Text] [Related]
43. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-374b accelerates the development of lung cancer through downregulating PTEN expression via activating PI3K/Akt pathway.
Li J; Zhou Z; Xu FC; Li J; Zeng D; Cao XQ; Han Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1116-1124. PubMed ID: 30779080
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of
Yao LZ; Zhu YL; Liu JJ
Technol Cancer Res Treat; 2020; 19():1533033820917959. PubMed ID: 32281513
[TBL] [Abstract][Full Text] [Related]
47. PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer.
Kim RJ; Bae E; Hong YK; Hong JY; Kim NK; Ahn HJ; Oh JJ; Park DS
Oncology; 2014; 87(5):270-9. PubMed ID: 25139413
[TBL] [Abstract][Full Text] [Related]
48. [Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line].
Ye MN; Chen HF; Zhou RJ; Liao MJ
Zhong Xi Yi Jie He Xue Bao; 2011 Dec; 9(12):1339-46. PubMed ID: 22152773
[TBL] [Abstract][Full Text] [Related]
49. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
[TBL] [Abstract][Full Text] [Related]
50. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway.
Hou Z; Quan J
Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072
[TBL] [Abstract][Full Text] [Related]
52. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
Tian J; Yuan L
Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
[TBL] [Abstract][Full Text] [Related]
53. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
[No Abstract] [Full Text] [Related]
54. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
55. Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.
Foster JS; Fish LM; Phipps JE; Bruker CT; Lewis JM; Bell JL; Solomon A; Kestler DP
BMC Cancer; 2013 May; 13():227. PubMed ID: 23648148
[TBL] [Abstract][Full Text] [Related]
56. The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer.
Weng M; Luo ZL; Wu XL; Zeng WZ
Oncotarget; 2017 Mar; 8(12):20288-20296. PubMed ID: 28423617
[TBL] [Abstract][Full Text] [Related]
57. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
58. (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN.
Liu S; Xu ZL; Sun L; Liu Y; Li CC; Li HM; Zhang W; Li CJ; Qin W
Mol Med Rep; 2016 Jul; 14(1):599-605. PubMed ID: 27176210
[TBL] [Abstract][Full Text] [Related]
59. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
[TBL] [Abstract][Full Text] [Related]
60. shRNA targeting PLCε inhibits bladder cancer cell growth in vitro and in vivo.
Cheng H; Luo C; Wu X; Zhang Y; He Y; Wu Q; Xia Y; Zhang J
Urology; 2011 Aug; 78(2):474.e7-11. PubMed ID: 21705050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]